Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DAWN – Day One Biopharmaceuticals, Inc.

Day One Biopharmaceuticals, Inc
DAWN
$7.22
Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $731,833,600.00
EPSttm : -0.65
finviz dynamic chart for DAWN
Day One Biopharmaceuticals, Inc
$7.22
3.88%
$0.27

Float Short %

24.68

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

0.02

EPS Last/This Y

-0.34

EPS This/Next Y

0.5

Price

6.95

Target Price

28

Analyst Recom

1.22

Performance Q

-23.63

Relative Volume

0.58

Beta

-1.3

Ticker: DAWN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07DAWN6.30.410.105102
2025-05-08DAWN6.740.420.175084
2025-05-09DAWN6.450.41999.995155
2025-05-12DAWN6.580.410.005155
2025-05-13DAWN6.340.300.024796
2025-05-14DAWN6.180.280.284969
2025-05-15DAWN6.160.280.075015
2025-05-16DAWN6.260.270.005120
2025-05-19DAWN6.470.270.004789
2025-05-20DAWN6.580.270.004874
2025-05-21DAWN6.30.27999.994895
2025-05-22DAWN6.270.271.924905
2025-05-23DAWN6.270.270.074938
2025-05-27DAWN6.310.270.945052
2025-05-28DAWN6.30.270.005074
2025-05-29DAWN6.480.260.005173
2025-05-30DAWN6.390.26999.995181
2025-06-02DAWN7.010.260.005186
2025-06-03DAWN6.960.260.105197
2025-06-04DAWN6.940.260.405318
2025-06-05DAWN6.940.260.045330
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07DAWN6.3039.0- -1.61
2025-05-08DAWN6.74-630.7- -1.50
2025-05-09DAWN6.45-630.7- -1.34
2025-05-12DAWN6.58-630.7- -1.34
2025-05-13DAWN6.33-583.4- -1.34
2025-05-14DAWN6.20-583.4- -1.34
2025-05-15DAWN6.16-583.4- -1.34
2025-05-16DAWN6.26-591.0- -1.36
2025-05-19DAWN6.48-591.0- -1.36
2025-05-20DAWN6.57-591.0- -1.36
2025-05-21DAWN6.30-591.0- -1.36
2025-05-22DAWN6.28-591.0- -1.36
2025-05-23DAWN6.28-591.0- -1.36
2025-05-27DAWN6.30-591.0- -1.36
2025-05-28DAWN6.31-591.0- -1.36
2025-05-29DAWN6.48-591.0- -1.36
2025-05-30DAWN6.38-591.0- -1.36
2025-06-02DAWN7.01-591.0- -1.36
2025-06-03DAWN6.98-591.0- -1.36
2025-06-04DAWN6.93-591.0- -1.36
2025-06-05DAWN6.95-591.0- -1.36
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07DAWN-0.40-0.3324.51
2025-05-08DAWN-0.40-0.3324.51
2025-05-09DAWN-0.36-0.3324.51
2025-05-12DAWN-0.360.0523.83
2025-05-13DAWN-0.260.0523.83
2025-05-14DAWN-0.260.0523.83
2025-05-15DAWN-0.260.0523.88
2025-05-16DAWN-0.260.0523.88
2025-05-19DAWN-0.26-5.0723.84
2025-05-20DAWN-0.29-5.0723.69
2025-05-21DAWN-0.29-5.0723.69
2025-05-22DAWN-0.29-5.0723.69
2025-05-23DAWN-0.29-5.0723.69
2025-05-27DAWN-0.290.4223.71
2025-05-28DAWN-0.290.4224.68
2025-05-29DAWN-0.290.4224.68
2025-05-30DAWN-0.290.4224.68
2025-06-02DAWN-0.290.7024.68
2025-06-03DAWN-0.290.7024.68
2025-06-04DAWN-0.290.7024.68
2025-06-05DAWN-0.290.7024.68
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.35

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.33

Insider Transactions

-0.29

Institutional Transactions

0.7

Beta

-1.3

Average Sales Estimate Current Quarter

35

Average Sales Estimate Next Quarter

40

Fair Value

Quality Score

46

Growth Score

25

Sentiment Score

35

Actual DrawDown %

75.8

Max Drawdown 5-Year %

Target Price

28

P/E

Forward P/E

PEG

P/S

4.35

P/B

1.47

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y​

-1.36

EPS Next Y. (Est.)

-0.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-42.66

Relative Volume

0.58

Return on Equity vs Sector %

-38.4

Return on Equity vs Industry %

-20.6

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.06

EBIT Estimation

Day One Biopharmaceuticals, Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading